Iraqi Journal of Pharmaceutical Sciences
Published by University of Baghdad - College of Pharmacy
ISSN : 1683-3597 eISSN : 2521-3512
Abbreviation : Iraqi J. Pharm. Sci.
Aims & Scope
Iraqi Journal of Pharmaceutical Sciences (IJPS) is a fully open access journal.
Open access (OA) refers to free, unrestricted online access to journal articles.
OA content is open to all, with no access fees.
For more information on Creative Commons Attribution licenses and the benefits of publishing open access.
View Aims & ScopeMetrics & Ranking
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 0.234 |
Quartile
Year | Value |
---|---|
2024 | Q3 |
h-index
Year | Value |
---|---|
2024 | 14 |
Journal Rank
Year | Value |
---|---|
2024 | 19337 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 410 |
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Chemistry, Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Policy Links
This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.
- Aims scope
- Homepage
- Oa statement
- Author instructions
- License terms
- Review url
- Board url
- Copyright url
- Plagiarism url
- Preservation url
- Apc url
- License
Plagiarism Policy
This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.
For more details, please refer to our official: Plagiarism Policy.
APC Details
The journal’s Article Processing Charge (APC) policies support open access publishing in Chemistry, Medicine and Pharmacology, Toxicology and Pharmaceutics, ensuring accessibility and quality in research dissemination.
This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 250,000.00 IQD. Learn more.
Explore journals without APCs for alternative publishing options.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Evaluation the Effectiveness of Phenolic Compound of Salvia Frigida on Induced Atopic Dermatitis in Experimental Mice
Citation: 21
Authors: Zahra, Tuka, Ahmed
-
Evaluation the Effect of Phytosterol Fraction of Chenopodium Murale in Comparison with Tacrolimus on Mice Induced Atopic Dermatitis
Citation: 20
Authors: Zahra, Tuka, Ahmed
-
Role of Topical Ritodrine Hydrochloride in Experimentally Induced Hypertrophic Scar in Rabbits
Citation: 18
Authors: Haitham, Fouad, Ahmed, Kholod
-
Formulation and Evaluation of Sustained Release Sumatriptan Mucoadhesive Intranasal in-Situ Gel
Citation: 18
Authors: Hussein K., Hanan J.
-
Effects of Vitamin D3 on Methotrexate- Induced Jejunum Damage in Rats
Citation: 13
Authors: Farah K., Nada N
-
Perceptions and attitudes of community pharmacists towards patient counseling and continuing pharmacy education programs in Iraq
Citation: 13
Authors: Samer I., Elaf B., Iman S.
-
Evaluation of the Clinical use of Metformin or Pioglitazone in Combination with Meloxicam in Patients with Knee Osteoarthritis; using Knee Injury and Osteoarthritis outcome Score
Citation: 13
Authors: Mohammed, Kassim, Nizar
-
Formulation and Evaluation of Iornoxicam as Dissolving Microneedle Patch
Citation: 13
Authors: Adeeb R., Mowafaq M.
-
Preparation, in vitro and ex-vivo Evaluation of Mirtazapine Nanosuspension and Nanoparticles Incorporated in Orodispersible Tablets
Citation: 12
Authors: Hiba E., Ahmed